secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stoke Therapeutics, Inc. (STOK)
CIK:        0001623526
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001193125-25-134882
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stoke Therapeutics shareholders elect three Class III directors at 2025 annual meeting
--------------------------------------------------------------------------------

- Edward M. Kaye, Seth L. Harrison, and Arthur O. Tzianabos elected as Class III directors with ~29.2M votes each.
- Ratification of KPMG as independent auditor for FY2025 approved with 38.7M for vs 67.8K against.
- Non-binding advisory vote on named executive officer compensation approved with 30.5M for vs 2.9M against.
- Advisory vote on frequency of future say-on-pay set at one year (33.1M votes) as preferred frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1623526/000119312525134882/0001193125-25-134882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1623526/000119312525134882/d936696d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-134882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer